Some of the world's leading makers of flu vaccines say they could make hundreds of millions of bird flu shots for humans within months if a new strain of avian influenza ever jumps across the species divide.
Hot off the successful deployment of mRNA vaccines for the prevention of COVID-19, three leading drugmakers have moved seasonal flu vaccine candidates built with the technology into early clinical testing. More companies intend to follow their.
A new study from the University of Chicago and Scripps Research Institute shows that during the last great pandemic 2009 s H1N1 influenza pandemic people developed strong, effective immune responses to stable, conserved parts of the virus.